Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

TPEX:3218 Revenue

Universal Vision Biotechnology had revenue of 1.08B TWD in the quarter ending September 30, 2024, with 1.70% growth. This brings the company's revenue in the last twelve months to 4.18B, up 3.36% year-over-year. In the year 2023, Universal Vision Biotechnology had annual revenue of 4.08B with 16.83% growth.

• Revenue (ttm): 4.18B
• Revenue Growth: +3.36%
• P/S Ratio: 4.74
• Revenue / Employee: 10.43M
• Employees: 401
• Market Cap: 19.83B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.08B	588.20M	16.83%
Dec 31, 2022	3.49B	862.26M	32.76%
Dec 31, 2021	2.63B	578.66M	28.18%
Dec 31, 2020	2.05B	634.16M	44.69%
Dec 31, 2019	1.42B	224.05M	18.75%